Tissue-Specific Bioinks: The bioink (biomaterial formulation used for bioprinting) is critical for engineering a functional tissue/organ as they provide biochemical and physical cues to promote cellular growth, proliferation, and differentiation. Our group works on the development of novel tissue-specific bioink that in combination with cells will give rise to native-like tissue.
3D/4D Bioprinted Tissue for Transplantation: The advancement of 3D/4D bioprinting has materialized as a new and innovative tissue engineering method to print cells in precise position for the generation of patient-defect-specific geometries. Our research focuses on the development of physiologically adaptable and functional tissue for transplantation in order to repair and regenerate injured tissue/organs.
Converged Biofabrication: Biofabrication technologies rely on single-component deposition methods, such as Bioprinting, Extrusion-based printing, or Inkjet. The complexity and functionality of living tissues cannot be replicated by any of these technologies alone. We converge these technologies into a single-step manufacturing procedure to engineer biologically functional tissue with more complex architecture and composition.